This mutation is strongly associated with late-onset ATTRv amyloid cardiomyopathy and represents the second most prevalent pathogenic TTR variant among individuals from a series of 23 countries worldwide, excluding the whole African continent and other large countries such as China, Russian, and India [18]. This evidence concerns the gene TTR and cardiac amyloidosis.